FinDogFinDog
Wednesday, September 16, 2026Closing data · 4:00 PM ET
English
Log in
FinDog Earnings CheckupEarnings release 08-04 · 10-Q 08-04Data from SEC filings

DuPont Q2 2026: sales up 4.0%, guidance raised to $7.24 adjusted EPS

DuPont beat on adjusted earnings and raised full-year guidance, so the quarter reads Bullish even though the headline GAAP profit looks much smaller. The gap is presentation, not performance: $1.88 adjusted EPS versus $1.05 GAAP, because the Aramids business now sits in discontinued operations. Read revenue growth, segment margins and cash conversion first, and treat the bottom line as noise.

1 · Expected vs. Actual

Free preview below
EPS (non-GAAP)
Beat
$1.88
Est. $1.81 · +3.7%

GAAP EPS of $1.05 sits far below the $1.88 adjusted figure, mostly because of a $0.32 per-share loss from discontinued operations and $0.39 of intangible amortization. Adjusted EPS beat the $1.8127 consensus by 3.7%. Watch the tags here: the filing's XBRL shows $143 million of net income and $1.05 EPS, while the extracted figures are $191 million and $1.37 — that is net income available to common stockholders versus continuing operations, not a restatement.

Revenue
$1.82B
No consensus · YoY +4.0%

Revenue of $1.819 billion rose 4.0% from $1.749 billion a year ago, and the whole move was organic — currency and portfolio changes contributed nothing at the total level. Both segments grew: Healthcare & Water Technologies added 5.0% (4% organic plus a 1% currency tailwind) and Diversified Industrials 3.0%. The quarter is also 8.2% above the $1.681 billion booked in the prior period.

Next-quarter revenue guidance
$7.17B
No consensus · YoY +294.4%

Management raised full-year 2026 guidance to $7.160–$7.190 billion of net sales, $1.750–$1.770 billion of operating EBITDA and $7.17–$7.32 of adjusted EPS. The company describes the operating EBITDA midpoint as about $1.76 billion and adjusted EPS as $7.24. The prior quarter's $1.800 billion guide was beaten by $19 million, or 1.1%.

Members Only

Log in to read 5 analyses a week for free

Create a free account to read 5 full earnings analyses each week — all five steps: expected vs. actual, guidance tracker, money flow, balance sheet and risks. Members get unlimited access.

Figures on this page come from the company's original SEC filings. The analysis is generated automatically and checked against validation rules, but may still contain errors or omissions. Not investment advice. · Generated 2026-09-17

Ask About This Report

Answers are based on the earnings release and the analysis above. Free accounts get 3 questions a week; members get 30 a day.

Log in to ask a question.